Evidence map›Paper›PMID 19896966›Full record

ReviewAdvances in enzyme regulation2010

The guanine nucleotide exchange factor (GEF) Ect2 is an oncogene in human cancer.

Alan P Fields, Verline Justilien

Abstract readReview
In one paragraph

Review in Advances in enzyme regulation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Integrative genomics analysis identifies candidate drivers at 3q26-29 amplicon in squamous cell carcinoma of the lung.Clinical cancer research : an official journal of the American Association for Cancer Research · 2013
    Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. The homeostatic regulation of ribosome biogenesis.Seminars in cell & developmental biology · 2023
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alan P FieldsDepartment of Cancer Biology, Mayo Clinic Comprehensive Cancer Center, Jacksonville, FL, USA. fields.alan@mayo.edu
Verline Justilien

Funding

Three-Dimensional Organoid Cultures to Investigate 3q26 Driver Functions in Multiple Lung Cancer Cells of OriginR01CA081436 · NCI · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI FIELDS, ALAN P. · 1999 to 2022
$9.9M
Atypical PKC signaling in lung cancer stem cellsR21CA151250 · NCI · MAYO CLINIC JACKSONVILLE · PI FIELDS, ALAN P. · 2010 to 2011
$529k
NCI NIH HHS CA081436-13NCI NIH HHS R01 CA081436NCI NIH HHS R21 CA151250
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Guanine Nucleotide Exchange FactorsNeoplasmsOncogenesProto-Oncogene ProteinsAnimalsCell Line, TumorCell Transformation, NeoplasticHumansLungProtein Structure, TertiaryRNA InterferenceSignal TransductionECT2 protein, humanGuanine Nucleotide Exchange FactorsProto-Oncogene Proteins

Identifiers

PMID19896966
PMCPMC2863999

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.